Correlation Between Aarey Drugs and Tata Consultancy

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aarey Drugs and Tata Consultancy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aarey Drugs and Tata Consultancy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aarey Drugs Pharmaceuticals and Tata Consultancy Services, you can compare the effects of market volatilities on Aarey Drugs and Tata Consultancy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarey Drugs with a short position of Tata Consultancy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarey Drugs and Tata Consultancy.

Diversification Opportunities for Aarey Drugs and Tata Consultancy

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Aarey and Tata is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Aarey Drugs Pharmaceuticals and Tata Consultancy Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tata Consultancy Services and Aarey Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarey Drugs Pharmaceuticals are associated (or correlated) with Tata Consultancy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tata Consultancy Services has no effect on the direction of Aarey Drugs i.e., Aarey Drugs and Tata Consultancy go up and down completely randomly.

Pair Corralation between Aarey Drugs and Tata Consultancy

Assuming the 90 days trading horizon Aarey Drugs Pharmaceuticals is expected to generate 2.34 times more return on investment than Tata Consultancy. However, Aarey Drugs is 2.34 times more volatile than Tata Consultancy Services. It trades about 0.03 of its potential returns per unit of risk. Tata Consultancy Services is currently generating about 0.04 per unit of risk. If you would invest  3,485  in Aarey Drugs Pharmaceuticals on October 30, 2024 and sell it today you would earn a total of  1,132  from holding Aarey Drugs Pharmaceuticals or generate 32.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aarey Drugs Pharmaceuticals  vs.  Tata Consultancy Services

 Performance 
       Timeline  
Aarey Drugs Pharmace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Tata Consultancy Services 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Tata Consultancy Services are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Tata Consultancy is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Aarey Drugs and Tata Consultancy Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aarey Drugs and Tata Consultancy

The main advantage of trading using opposite Aarey Drugs and Tata Consultancy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarey Drugs position performs unexpectedly, Tata Consultancy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tata Consultancy will offset losses from the drop in Tata Consultancy's long position.
The idea behind Aarey Drugs Pharmaceuticals and Tata Consultancy Services pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account